No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
UAE – Swiss biotechnology company Rejuveron has completed a US$75M series B financing round with a significant investment from Mubadala, an investment firm headquartered in Abu Dhabi. Rejuveron is a…
Read More
USA — Alnylam Pharmaceuticals, in collaboration with Roche, is advancing rapidly with its groundbreaking RNAi therapeutic, zilebesiran, following their July 2023 partnership. Exciting news emerged as the Cambridge-based biotech unveiled…
Read More
SWITZERLAND — Novartis, in the midst of a major organizational overhaul, is facing a significant leadership change as Marie-France Tschudin, the current president of Innovative Medicine International, has chosen to…
Read More
SWITZERLAND — In a significant strategic move, Novartis has reaffirmed its commitment to the spin-off of its generics and biosimilars division, Sandoz. The progression of this initiative hinges on obtaining…
Read More
SWITZERLAND — Nestlé has divested its peanut-allergy medicine business, Palforzia, to Swiss biopharmaceutical company Stallergenes Greer. This decision follows Nestlé’s announcement last year regarding a comprehensive review of Palforzia’s future…
Read More
SWITZERLAND —In a significant stride towards combatting cardiovascular disease, a recent three-year follow-up trial has underscored the unwavering efficacy of Leqvio (inclisiran) when used alongside statin therapy. The groundbreaking treatment…
Read More
SWITZERLAND — The collaboration between the World Health Organization (WHO) and the G20 India presidency has given birth to the Global Initiative on Digital Health (GIDH). This announcement was made…
Read More
SWITZERLAND —The inaugural World Health Organization (WHO) Global Summit on Traditional Medicine 2023 has concluded with a resounding commitment from partner organizations and stakeholders to harness the potential of evidence-based…
Read More
SWITZERLAND — In a critical move, the World Health Organization (WHO) has designated the EG.5 coronavirus strain circulating in the United States and China as a “variant of interest.” Despite…
Read More
SWITZERLAND— In a year marked by unprecedented challenges in the pharmaceutical industry, Roche, the Swiss drugs and diagnostics giant, showcased its resilience and innovative prowess. The company’s first-half core operating…
Read More